Skip navigation

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Results 1 - 10 of 10 for ALK inhibitor
  1. Advances in Lung Cancer Research From the National Institutes of Health (National Cancer Institute)  
    Lung Cancer/Statistics and Research ... Lung Cancer ... National Cancer Institute ... From the National Institutes of Health ... Learn what's new in lung cancer research ...
    https://www.cancer.gov/types/lung/research - External Health Links
  2. Lung cancer 
    ... selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International ... selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International ...
    https://medlineplus.gov/genetics/condition/lung-cancer - Genetics
  3. EGFR gene 
    ... selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International ...
    https://medlineplus.gov/genetics/gene/egfr - Genetics
  4. ALK gene 
    ... Tests of ALK PubMed ALK RECEPTOR TYROSINE KINASE; ALK LUNG CANCER NCBI Gene ClinVar Ardini E, Magnaghi P, Orsini P, Galvani A, Menichincheri M. Anaplastic Lymphoma Kinase: role in specific tumours, and development of small molecule inhibitors for cancer therapy. Cancer Lett. 2010 Dec 28; ...
    https://medlineplus.gov/genetics/gene/alk - Genetics
  5. Neuroblastoma 
    ... condition is called familial neuroblastoma. Mutations in the ALK and PHOX2B genes have been shown to increase ... the formation of neuroblastoma.Several mutations in the ALK gene are involved in the development of sporadic ...
    https://medlineplus.gov/genetics/condition/neuroblastoma - Genetics
  6. Neuroblastoma Treatment From the National Institutes of Health (National Cancer Institute)  
    Neuroblastoma/Treatments and Therapies ... Neuroblastoma ... National Cancer Institute ... From the National Institutes of Health ... Neuroblastoma treatment may include ...
    https://www.cancer.gov/.../patient/neuroblastoma-treatment-pdq - External Health Links
  7. Stages of Adult Non-Hodgkin Lymphoma From the National Institutes of Health (National Cancer Institute)  
    Lymphoma/Diagnosis and Tests ... Lymphoma ... National Cancer Institute ... Non-Hodgkin lymphoma (NHL) options include chemotherapy, radiation, targeted therapy, plasmapheresis, ...
    https://www.cancer.gov/.../patient/adult-nhl-treatment-pdq#_158 - External Health Links
  8. General Information about Adult Non-Hodgkin Lymphoma From the National Institutes of Health (National Cancer Institute)  
    Lymphoma/Start Here ... Lymphoma ... National Cancer Institute ... From the National Institutes of Health ... Non-Hodgkin lymphoma (NHL) options include chemotherapy, radiation, ...
    https://www.cancer.gov/.../patient/adult-nhl-treatment-pdq#_129 - External Health Links
  9. Treatment Option Overview (Adult Non-Hodgkin Lymphoma) From the National Institutes of Health (National Cancer Institute)  
    Lymphoma/Treatments and Therapies ... Lymphoma ... National Cancer Institute ... From the National Institutes of Health ... Non-Hodgkin lymphoma (NHL) options include chemotherapy, ...
    https://www.cancer.gov/.../patient/adult-nhl-treatment-pdq#_190 - External Health Links
  10. Immunotherapy Drugs Expand Treatment Options for Advanced Lung Cancer From the National Institutes of Health (National Cancer Institute)  
    ... large clinical trial show combining the immune checkpoint inhibitor pembrolizumab (Keytruda) with chemotherapy helped some patients with ...
    https://www.cancer.gov/.../2018/pembrolizumab-lung-cancer-first-line - External Health Links